PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Drug Actiq (Fentanyl Citrate)- FDA 1 1 0.00 -0.71 1.00 0.57
Cancer 1,053,491 Disease Drug Abeohyousterone 1 1 0.00 -0.71 1.00 0.57
Cancer 1,053,491 Disease Disease Sever Condition 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Alli (Orlistat 60 mg)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Dragonamide E 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Dromostanolone Propionate 3 2 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Drug Aminoglutethimide (Cytadren)- FDA 3 2 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Drug Acarbose (Precose)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 3 0.00 -0.50 0.75 0.57
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Ancobon (Flucytosine)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Drimenin 4 2 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Dragonamide 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target Nad-Dependent Protein Deacetylase Sirtuin-1 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target CCL27/CTACK 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target Small Inducible Cytokine A2 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Drug Abarelix (Plenaxis)- FDA 5 4 0.00 -0.45 0.80 0.57
Cancer 1,053,491 Disease Disease Carcinoma Endometrial 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target E9 protein 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Drug Acular (Ketorolac Tromethamine)- FDA 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Disease Carcinoma Renal 6 4 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Aromasin (Exemestane)- FDA 7 6 0.00 -0.38 0.86 0.58
Cancer 1,053,491 Disease Drug Abciximab (ReoPro)- FDA 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Drug Kabiramide C 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Drug Avodart (Dutasteride)- FDA 7 4 0.00 -0.65 0.57 0.57
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Dromostanolone 8 3 0.00 -0.79 0.38 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 6 0.00 -0.50 0.75 0.58
Cancer 1,053,491 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Drug Doxoform 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Drug Doxazolidine 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Drug Aloxi (Palonosetron hydrochloride)- FDA 10 4 0.00 -0.77 0.40 0.56
Cancer 1,053,491 Disease Drug Drometrizole 10 3 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Drug Axitinib (Inlyta)- FDA 10 7 0.00 -0.55 0.70 0.57
Cancer 1,053,491 Disease Drug Anastrozole (Arimidex)- FDA 10 9 0.00 -0.32 0.90 0.58
Cancer 1,053,491 Disease Target ACAD8 11 1 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.55